Exercise for Elderly Lymphoma Patients
Exercise Training is a Feasible and Active Complementary Therapy in Adult and Elderly Patients Receiving Anti- Lymphoma Treatments
1 other identifier
interventional
30
1 country
1
Brief Summary
This pilot study was designed in a real-life setting to establish the feasibility, the safety and the activity of a supervised and combined Exercise Training (ET) program in adult and elderly lymphoma patients undergoing cancer-treatments.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jan 2016
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 2, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 31, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
May 31, 2018
CompletedFirst Submitted
Initial submission to the registry
February 5, 2020
CompletedFirst Posted
Study publicly available on registry
February 6, 2020
CompletedFebruary 6, 2020
February 1, 2020
2.4 years
February 5, 2020
February 5, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (5)
The eligibility rate
the eligibility rate was assessed by the number of eligible patients divided by the total number of elements on the sampling frame.
6 months
The recruitment rate
the recruitment rate was assessed by the number of patients included in the study divided by the total number of eligible patients
6 months
The exercise adherence rate
The exercise adherence rate was assessed by the number of exercise sessions attended out of the 48 sessions scheduled for each patient
4 months
The assessment rate
The assessment rate was assessed by the number of patients who completed the T1 and T2 follow-up times over the total number who participated in the study
6 months
Safety of the exercise training
Safety was assessed by monitoring any serious adverse events that occured during the ET period.
6 months
Study Arms (2)
Exercise Training Group
EXPERIMENTALExercise training group performed three weekly sessions for 16 weeks. This program consisted of moderate intensity aerobic, resistance, balance, and stretching exercises. The duration of every exercise session was 35 minutes during the first week and 65 minutes from the second week onward.
Control Group
NO INTERVENTIONThe control group received usual lymphoma care
Interventions
Eligibility Criteria
You may qualify if:
- ≥18-80 years old, histologically confirmed HL or NHL, patients in need of first or subsequent lines of systemic treatment and with a long-life expectancy
You may not qualify if:
- Patients were excluded if they had less than 4 months of anti-cancer treatment to be delivered, severe orthopaedic, cardiac, pulmonary, or cognitive impairment, osteolytic lesions with the risk of fracture, cachexia or if they were ≥ 65 years and frail on the basis of comprehensive geriatric assessment
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Sant'Andrea Hospital
Rome, 00189, Italy
Related Publications (1)
Streckmann F, Kneis S, Leifert JA, Baumann FT, Kleber M, Ihorst G, Herich L, Grussinger V, Gollhofer A, Bertz H. Exercise program improves therapy-related side-effects and quality of life in lymphoma patients undergoing therapy. Ann Oncol. 2014 Feb;25(2):493-9. doi: 10.1093/annonc/mdt568.
PMID: 24478323BACKGROUND
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Maria Christina Cox
Sant'Andrea Hospital, Rome, Italy
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD, PhD
Study Record Dates
First Submitted
February 5, 2020
First Posted
February 6, 2020
Study Start
January 2, 2016
Primary Completion
May 31, 2018
Study Completion
May 31, 2018
Last Updated
February 6, 2020
Record last verified: 2020-02
Data Sharing
- IPD Sharing
- Will not share